IL202701A - Intentional cell death - Google Patents

Info

Publication number

IL202701A

IL202701A IL202701A IL20270109A IL202701A IL 202701 A IL202701 A IL 202701A IL 202701 A IL202701 A IL 202701A IL 20270109 A IL20270109 A IL 20270109A IL 202701 A IL202701 A IL 202701A

Authority

IL

Israel

Prior art keywords

cell

protein

animal

cells

cdmp

Prior art date

2007-06-12

Links

• Espacenet
• Global Dossier
• Discuss

• 230000030833 cell death Effects 0.000 title claims description 106
• 238000000034 method Methods 0.000 claims abstract description 111
• 201000001119 neuropathy Diseases 0.000 claims abstract description 22
• 230000007823 neuropathy Effects 0.000 claims abstract description 22
• 208000033808 peripheral neuropathy Diseases 0.000 claims abstract description 22
• 238000012216 screening Methods 0.000 claims abstract description 11
• 210000004027 cell Anatomy 0.000 claims description 344
• 108090000623 proteins and genes Proteins 0.000 claims description 203
• 241001465754 Metazoa Species 0.000 claims description 152
• 230000014509 gene expression Effects 0.000 claims description 140
• 102000004169 proteins and genes Human genes 0.000 claims description 119
• 210000004248 oligodendroglia Anatomy 0.000 claims description 111
• 210000002569 neuron Anatomy 0.000 claims description 83
• 239000003795 chemical substances by application Substances 0.000 claims description 76
• 208000016192 Demyelinating disease Diseases 0.000 claims description 72
• 206010012305 Demyelination Diseases 0.000 claims description 69
• 230000006907 apoptotic process Effects 0.000 claims description 64
• 230000001939 inductive effect Effects 0.000 claims description 62
• 230000000694 effects Effects 0.000 claims description 56
• 150000007523 nucleic acids Chemical class 0.000 claims description 56
• 230000001105 regulatory effect Effects 0.000 claims description 53
• 210000003169 central nervous system Anatomy 0.000 claims description 50
• 230000009261 transgenic effect Effects 0.000 claims description 42
• 201000006417 multiple sclerosis Diseases 0.000 claims description 41
• 108090000566 Caspase-9 Proteins 0.000 claims description 40
• 102000004039 Caspase-9 Human genes 0.000 claims description 39
• 102000039446 nucleic acids Human genes 0.000 claims description 39
• 108020004707 nucleic acids Proteins 0.000 claims description 39
• 230000001537 neural effect Effects 0.000 claims description 37
• 210000003050 axon Anatomy 0.000 claims description 34
• 239000003550 marker Substances 0.000 claims description 33
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 32
• 239000003446 ligand Substances 0.000 claims description 32
• 210000004498 neuroglial cell Anatomy 0.000 claims description 31
• CJLHTKGWEUGORV-UHFFFAOYSA-N Artemin Chemical compound C1CC2(C)C(O)CCC(=C)C2(O)C2C1C(C)C(=O)O2 CJLHTKGWEUGORV-UHFFFAOYSA-N 0.000 claims description 28
• KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 claims description 26
• 210000001130 astrocyte Anatomy 0.000 claims description 26
• 208000035475 disorder Diseases 0.000 claims description 23
• 210000003061 neural cell Anatomy 0.000 claims description 21
• 125000003729 nucleotide group Chemical group 0.000 claims description 21
• 210000004116 schwann cell Anatomy 0.000 claims description 21
• 239000013543 active substance Substances 0.000 claims description 20
• 210000005046 glial fibrillary acidic protein Anatomy 0.000 claims description 19
• 101710193519 Glial fibrillary acidic protein Proteins 0.000 claims description 18
• 102100039289 Glial fibrillary acidic protein Human genes 0.000 claims description 18
• 108010033644 N-acylsphingosine galactosyltransferase Proteins 0.000 claims description 18
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 18
• 108010005298 Oligodendrocyte-Myelin Glycoprotein Proteins 0.000 claims description 18
• 102100026746 Oligodendrocyte-myelin glycoprotein Human genes 0.000 claims description 18
• 102100035917 Peripheral myelin protein 22 Human genes 0.000 claims description 18
• 101710199257 Peripheral myelin protein 22 Proteins 0.000 claims description 18
• 108020001507 fusion proteins Proteins 0.000 claims description 18
• 102000037865 fusion proteins Human genes 0.000 claims description 18
• 101000909851 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) cAMP/cGMP dual specificity phosphodiesterase Rv0805 Proteins 0.000 claims description 17
• 102000055325 Myelin P0 Human genes 0.000 claims description 17
• 108050003852 Myelin protein P0 Proteins 0.000 claims description 17
• 230000008499 blood brain barrier function Effects 0.000 claims description 16
• 210000001218 blood-brain barrier Anatomy 0.000 claims description 16
• 238000006471 dimerization reaction Methods 0.000 claims description 16
• 239000002773 nucleotide Substances 0.000 claims description 16
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 16
• 102100026376 Artemin Human genes 0.000 claims description 14
• 101710205806 Artemin Proteins 0.000 claims description 14
• 230000002025 microglial effect Effects 0.000 claims description 14
• 102100021584 Neurturin Human genes 0.000 claims description 12
• 108010015406 Neurturin Proteins 0.000 claims description 12
• 102100036660 Persephin Human genes 0.000 claims description 12
• 108010070453 persephin Proteins 0.000 claims description 12
• 239000000126 substance Substances 0.000 claims description 11
• 230000002518 glial effect Effects 0.000 claims description 10
• 108010077641 Nogo Proteins Proteins 0.000 claims description 9
• 108010051742 Platelet-Derived Growth Factor beta Receptor Proteins 0.000 claims description 9
• 102100026547 Platelet-derived growth factor receptor beta Human genes 0.000 claims description 9
• 108010010974 Proteolipids Proteins 0.000 claims description 9
• 102000016202 Proteolipids Human genes 0.000 claims description 9
• 102100029831 Reticulon-4 Human genes 0.000 claims description 9
• 239000000411 inducer Substances 0.000 claims description 9
• 230000004913 activation Effects 0.000 claims description 8
• 230000001640 apoptogenic effect Effects 0.000 claims description 8
• 230000001737 promoting effect Effects 0.000 claims description 8
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 7
• 108010036280 Aquaporin 4 Proteins 0.000 claims description 7
• 102000012002 Aquaporin 4 Human genes 0.000 claims description 7
• 102000004091 Caspase-8 Human genes 0.000 claims description 7
• 108090000538 Caspase-8 Proteins 0.000 claims description 7
• 230000003213 activating effect Effects 0.000 claims description 7
• 230000007423 decrease Effects 0.000 claims description 7
• 210000003668 pericyte Anatomy 0.000 claims description 7
• 102100035904 Caspase-1 Human genes 0.000 claims description 6
• 108090000426 Caspase-1 Proteins 0.000 claims description 6
• 102000004068 Caspase-10 Human genes 0.000 claims description 6
• 108090000572 Caspase-10 Proteins 0.000 claims description 6
• 102000004046 Caspase-2 Human genes 0.000 claims description 6
• 108090000552 Caspase-2 Proteins 0.000 claims description 6
• 102100038916 Caspase-5 Human genes 0.000 claims description 6
• 101710090333 Caspase-5 Proteins 0.000 claims description 6
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims description 6
• 229930105110 Cyclosporin A Natural products 0.000 claims description 6
• 108010036949 Cyclosporine Proteins 0.000 claims description 6
• 239000004098 Tetracycline Substances 0.000 claims description 6
• 229960001265 ciclosporin Drugs 0.000 claims description 6
• 229930182912 cyclosporin Natural products 0.000 claims description 6
• 150000003431 steroids Chemical class 0.000 claims description 6
• 229960002180 tetracycline Drugs 0.000 claims description 6
• 229930101283 tetracycline Natural products 0.000 claims description 6
• 235000019364 tetracycline Nutrition 0.000 claims description 6
• 150000003522 tetracyclines Chemical class 0.000 claims description 6
• 230000035699 permeability Effects 0.000 claims description 5
• 125000006414 CCl Chemical group ClC* 0.000 claims description 4
• 108091034117 Oligonucleotide Proteins 0.000 claims description 4
• -1 PDGFR-a Proteins 0.000 claims description 4
• 241000283984 Rodentia Species 0.000 claims description 4
• 230000007547 defect Effects 0.000 claims description 4
• 108020004459 Small interfering RNA Proteins 0.000 claims description 3
• 150000002894 organic compounds Chemical class 0.000 claims description 3
• 239000004055 small Interfering RNA Substances 0.000 claims description 3
• 241000894007 species Species 0.000 claims description 3
• 239000000074 antisense oligonucleotide Substances 0.000 claims description 2
• 238000012230 antisense oligonucleotides Methods 0.000 claims description 2
• 150000002484 inorganic compounds Chemical class 0.000 claims description 2
• 229910010272 inorganic material Inorganic materials 0.000 claims description 2
• 101000870345 Vasconcellea cundinamarcensis Cysteine proteinase 1 Proteins 0.000 claims 2
• YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims 1
• CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims 1
• 101150057744 PDGFA gene Proteins 0.000 claims 1
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 claims 1
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 claims 1
• 229940106189 ceramide Drugs 0.000 claims 1
• ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims 1
• VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims 1
• 239000000203 mixture Substances 0.000 abstract description 21
• 230000001225 therapeutic effect Effects 0.000 abstract description 4
• 235000018102 proteins Nutrition 0.000 description 109
• 230000003902 lesion Effects 0.000 description 68
• 241000700159 Rattus Species 0.000 description 55
• 241000700605 Viruses Species 0.000 description 49
• 238000012360 testing method Methods 0.000 description 43
• 210000000278 spinal cord Anatomy 0.000 description 42
• 239000013598 vector Substances 0.000 description 41
• 210000001519 tissue Anatomy 0.000 description 40
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 39
• 230000001154 acute effect Effects 0.000 description 35
• 210000004556 brain Anatomy 0.000 description 35
• 230000004044 response Effects 0.000 description 34
• 238000001727 in vivo Methods 0.000 description 32
• 230000003210 demyelinating effect Effects 0.000 description 30
• 208000015181 infectious disease Diseases 0.000 description 25
• 108010048367 enhanced green fluorescent protein Proteins 0.000 description 24
• 238000000338 in vitro Methods 0.000 description 24
• 102000006386 Myelin Proteins Human genes 0.000 description 22
• 108010083674 Myelin Proteins Proteins 0.000 description 22
• 210000005012 myelin Anatomy 0.000 description 22
• 239000000047 product Substances 0.000 description 22
• 239000007924 injection Substances 0.000 description 20
• 238000002347 injection Methods 0.000 description 20
• 102000040430 polynucleotide Human genes 0.000 description 20
• 108091033319 polynucleotide Proteins 0.000 description 20
• 239000002157 polynucleotide Substances 0.000 description 20
• 238000010186 staining Methods 0.000 description 20
• 102000047918 Myelin Basic Human genes 0.000 description 19
• 108700019146 Transgenes Proteins 0.000 description 19
• 150000001875 compounds Chemical class 0.000 description 19
• 230000003612 virological effect Effects 0.000 description 19
• 101710107068 Myelin basic protein Proteins 0.000 description 18
• 230000001054 cortical effect Effects 0.000 description 18
• 230000034994 death Effects 0.000 description 17
• 238000004458 analytical method Methods 0.000 description 16
• 238000002474 experimental method Methods 0.000 description 16
• 239000005090 green fluorescent protein Substances 0.000 description 16
• 239000013603 viral vector Substances 0.000 description 16
• 238000001514 detection method Methods 0.000 description 15
• 108010076667 Caspases Proteins 0.000 description 14
• 238000003556 assay Methods 0.000 description 14
• 210000003205 muscle Anatomy 0.000 description 14
• 102000011727 Caspases Human genes 0.000 description 13
• 241000713666 Lentivirus Species 0.000 description 13
• 238000004113 cell culture Methods 0.000 description 13
• 238000000386 microscopy Methods 0.000 description 13
• 210000002161 motor neuron Anatomy 0.000 description 13
• 108020004414 DNA Proteins 0.000 description 12
• 230000006378 damage Effects 0.000 description 12
• 230000006698 induction Effects 0.000 description 12
• 238000002372 labelling Methods 0.000 description 12
• 230000023105 myelination Effects 0.000 description 12
• 238000010171 animal model Methods 0.000 description 11
• 238000003384 imaging method Methods 0.000 description 11
• 230000004770 neurodegeneration Effects 0.000 description 11
• 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 10
• 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 10
• 108010025020 Nerve Growth Factor Proteins 0.000 description 10
• 239000012867 bioactive agent Substances 0.000 description 10
• 238000009396 hybridization Methods 0.000 description 10
• 230000008569 process Effects 0.000 description 10
• 239000003981 vehicle Substances 0.000 description 10
• 201000010099 disease Diseases 0.000 description 9
• 108020004999 messenger RNA Proteins 0.000 description 9
• 230000008906 neuronal response Effects 0.000 description 9
• 102000005962 receptors Human genes 0.000 description 9
• 108020003175 receptors Proteins 0.000 description 9
• 230000008439 repair process Effects 0.000 description 9
• 210000003523 substantia nigra Anatomy 0.000 description 9
• 238000012353 t test Methods 0.000 description 9
• 241000701161 unidentified adenovirus Species 0.000 description 9
• 108010013731 Myelin-Associated Glycoprotein Proteins 0.000 description 8
• 102000017099 Myelin-Associated Glycoprotein Human genes 0.000 description 8
• 108010000123 Myelin-Oligodendrocyte Glycoprotein Proteins 0.000 description 8
• 102000002233 Myelin-Oligodendrocyte Glycoprotein Human genes 0.000 description 8
• 238000000692 Student's t-test Methods 0.000 description 8
• 238000002679 ablation Methods 0.000 description 8
• 230000003376 axonal effect Effects 0.000 description 8
• 238000006243 chemical reaction Methods 0.000 description 8
• 239000002299 complementary DNA Substances 0.000 description 8
• 230000002068 genetic effect Effects 0.000 description 8
• 102000004196 processed proteins & peptides Human genes 0.000 description 8
• 206010061218 Inflammation Diseases 0.000 description 7
• 229940024606 amino acid Drugs 0.000 description 7
• 235000001014 amino acid Nutrition 0.000 description 7
• 150000001413 amino acids Chemical class 0.000 description 7
• 239000003814 drug Substances 0.000 description 7
• 230000004054 inflammatory process Effects 0.000 description 7
• 239000002609 medium Substances 0.000 description 7
• 210000001428 peripheral nervous system Anatomy 0.000 description 7
• 239000013612 plasmid Substances 0.000 description 7
• 229920001184 polypeptide Polymers 0.000 description 7
• 230000002062 proliferating effect Effects 0.000 description 7
• 230000004083 survival effect Effects 0.000 description 7
• 206010003694 Atrophy Diseases 0.000 description 6
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 6
• 208000027418 Wounds and injury Diseases 0.000 description 6
• 230000037444 atrophy Effects 0.000 description 6
• 230000006870 function Effects 0.000 description 6
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
• 239000010931 gold Substances 0.000 description 6
• 229910052737 gold Inorganic materials 0.000 description 6
• 238000011503 in vivo imaging Methods 0.000 description 6
• 230000002757 inflammatory effect Effects 0.000 description 6
• 208000014674 injury Diseases 0.000 description 6
• 230000003447 ipsilateral effect Effects 0.000 description 6
• 239000002502 liposome Substances 0.000 description 6
• 210000001161 mammalian embryo Anatomy 0.000 description 6
• 230000001404 mediated effect Effects 0.000 description 6
• 210000005036 nerve Anatomy 0.000 description 6
• 210000000653 nervous system Anatomy 0.000 description 6
• 210000000535 oligodendrocyte precursor cell Anatomy 0.000 description 6
• 230000037361 pathway Effects 0.000 description 6
• 230000010076 replication Effects 0.000 description 6
• 230000002123 temporal effect Effects 0.000 description 6
• 210000000115 thoracic cavity Anatomy 0.000 description 6
• 238000012546 transfer Methods 0.000 description 6
• 229920002307 Dextran Polymers 0.000 description 5
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
• 241000699666 Mus <mouse, genus> Species 0.000 description 5
• 241000699670 Mus sp. Species 0.000 description 5
• 102000015336 Nerve Growth Factor Human genes 0.000 description 5
• 102000007072 Nerve Growth Factors Human genes 0.000 description 5
• 108091008606 PDGF receptors Proteins 0.000 description 5
• 208000018737 Parkinson disease Diseases 0.000 description 5
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 5
• 210000001744 T-lymphocyte Anatomy 0.000 description 5
• 102000040945 Transcription factor Human genes 0.000 description 5
• 108091023040 Transcription factor Proteins 0.000 description 5
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 5
• 230000002424 anti-apoptotic effect Effects 0.000 description 5
• 210000000170 cell membrane Anatomy 0.000 description 5
• 230000001413 cellular effect Effects 0.000 description 5
• 230000001684 chronic effect Effects 0.000 description 5
• 210000000877 corpus callosum Anatomy 0.000 description 5
• 230000001419 dependent effect Effects 0.000 description 5
• 238000009826 distribution Methods 0.000 description 5
• 210000002889 endothelial cell Anatomy 0.000 description 5
• 239000012634 fragment Substances 0.000 description 5
• 239000007788 liquid Substances 0.000 description 5
• 238000012423 maintenance Methods 0.000 description 5
• 239000012528 membrane Substances 0.000 description 5
• 210000003007 myelin sheath Anatomy 0.000 description 5
• 229940053128 nerve growth factor Drugs 0.000 description 5
• 239000003900 neurotrophic factor Substances 0.000 description 5
• 239000008194 pharmaceutical composition Substances 0.000 description 5
• 229920000642 polymer Polymers 0.000 description 5
• 238000002360 preparation method Methods 0.000 description 5
• 230000000750 progressive effect Effects 0.000 description 5
• 239000000523 sample Substances 0.000 description 5
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 5
• 239000006228 supernatant Substances 0.000 description 5
• 238000011282 treatment Methods 0.000 description 5
• 230000009385 viral infection Effects 0.000 description 5
• WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 4
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 4
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 4
• 206010010099 Combined immunodeficiency Diseases 0.000 description 4
• 241000701022 Cytomegalovirus Species 0.000 description 4
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 4
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 4
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 4
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 4
• 102000001398 Granzyme Human genes 0.000 description 4
• 108060005986 Granzyme Proteins 0.000 description 4
• 101001133605 Homo sapiens Parkin coregulated gene protein Proteins 0.000 description 4
• 241000124008 Mammalia Species 0.000 description 4
• GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 4
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 4
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 4
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
• 102000009659 Vesicular Monoamine Transport Proteins Human genes 0.000 description 4
• 108010020033 Vesicular Monoamine Transport Proteins Proteins 0.000 description 4
• 239000000427 antigen Substances 0.000 description 4
• 108091007433 antigens Proteins 0.000 description 4
• 102000036639 antigens Human genes 0.000 description 4
• 238000013459 approach Methods 0.000 description 4
• 238000010256 biochemical assay Methods 0.000 description 4
• 230000036755 cellular response Effects 0.000 description 4
• 230000002596 correlated effect Effects 0.000 description 4
• 230000000875 corresponding effect Effects 0.000 description 4
• 210000004748 cultured cell Anatomy 0.000 description 4
• 230000004069 differentiation Effects 0.000 description 4
• 238000010790 dilution Methods 0.000 description 4
• 239000012895 dilution Substances 0.000 description 4
• 239000003623 enhancer Substances 0.000 description 4
• 239000013604 expression vector Substances 0.000 description 4
• 239000000284 extract Substances 0.000 description 4
• 229940126864 fibroblast growth factor Drugs 0.000 description 4
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
• 230000001744 histochemical effect Effects 0.000 description 4
• 239000001257 hydrogen Substances 0.000 description 4
• 229910052739 hydrogen Inorganic materials 0.000 description 4
• 230000000977 initiatory effect Effects 0.000 description 4
• 230000003993 interaction Effects 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 238000010208 microarray analysis Methods 0.000 description 4
• 230000004048 modification Effects 0.000 description 4
• 238000012986 modification Methods 0.000 description 4
• 230000003562 morphometric effect Effects 0.000 description 4
• 238000013425 morphometry Methods 0.000 description 4
• 230000000508 neurotrophic effect Effects 0.000 description 4
• 230000001575 pathological effect Effects 0.000 description 4
• 230000007170 pathology Effects 0.000 description 4
• 238000012545 processing Methods 0.000 description 4
• 210000000463 red nucleus Anatomy 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
• SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
• 210000000130 stem cell Anatomy 0.000 description 4
• 230000004960 subcellular localization Effects 0.000 description 4
• 208000011580 syndromic disease Diseases 0.000 description 4
• 238000001890 transfection Methods 0.000 description 4
• 102000003390 tumor necrosis factor Human genes 0.000 description 4
• 241001430294 unidentified retrovirus Species 0.000 description 4
• 102100024643 ATP-binding cassette sub-family D member 1 Human genes 0.000 description 3
• 201000011452 Adrenoleukodystrophy Diseases 0.000 description 3
• 108091007065 BIRCs Proteins 0.000 description 3
• 102000021350 Caspase recruitment domains Human genes 0.000 description 3
• 108091011189 Caspase recruitment domains Proteins 0.000 description 3
• 108090000994 Catalytic RNA Proteins 0.000 description 3
• 102000053642 Catalytic RNA Human genes 0.000 description 3
• 241000282693 Cercopithecidae Species 0.000 description 3
• 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 3
• 102000009058 Death Domain Receptors Human genes 0.000 description 3
• 108010049207 Death Domain Receptors Proteins 0.000 description 3
• 206010012289 Dementia Diseases 0.000 description 3
• 102100033189 Diablo IAP-binding mitochondrial protein Human genes 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 102000015212 Fas Ligand Protein Human genes 0.000 description 3
• 108010039471 Fas Ligand Protein Proteins 0.000 description 3
• 208000003098 Ganglion Cysts Diseases 0.000 description 3
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
• 241000714192 Human spumaretrovirus Species 0.000 description 3
• 102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 description 3
• 108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 description 3
• 241001529936 Murinae Species 0.000 description 3
• 101000933115 Mus musculus Caspase-4 Proteins 0.000 description 3
• 108090000742 Neurotrophin 3 Proteins 0.000 description 3
• 102100029268 Neurotrophin-3 Human genes 0.000 description 3
• 241000283973 Oryctolagus cuniculus Species 0.000 description 3
• 206010069350 Osmotic demyelination syndrome Diseases 0.000 description 3
• 241000711798 Rabies lyssavirus Species 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 102000019197 Superoxide Dismutase Human genes 0.000 description 3
• 108010012715 Superoxide dismutase Proteins 0.000 description 3
• 208000005400 Synovial Cyst Diseases 0.000 description 3
• 238000012288 TUNEL assay Methods 0.000 description 3
• 108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 3
• 102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 3
• 208000036142 Viral infection Diseases 0.000 description 3
• 239000012190 activator Substances 0.000 description 3
• 239000002671 adjuvant Substances 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 3
• 238000000423 cell based assay Methods 0.000 description 3
• 210000003703 cisterna magna Anatomy 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 238000004624 confocal microscopy Methods 0.000 description 3
• 210000003618 cortical neuron Anatomy 0.000 description 3
• 210000005064 dopaminergic neuron Anatomy 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 230000009977 dual effect Effects 0.000 description 3
• 210000005216 enteric neuron Anatomy 0.000 description 3
• 230000005284 excitation Effects 0.000 description 3
• 239000012091 fetal bovine serum Substances 0.000 description 3
• 239000012894 fetal calf serum Substances 0.000 description 3
• 238000000799 fluorescence microscopy Methods 0.000 description 3
• 108091006047 fluorescent proteins Proteins 0.000 description 3
• 102000034287 fluorescent proteins Human genes 0.000 description 3
• 239000001963 growth medium Substances 0.000 description 3
• 230000036541 health Effects 0.000 description 3
• 238000003119 immunoblot Methods 0.000 description 3
• 238000011532 immunohistochemical staining Methods 0.000 description 3
• 230000002401 inhibitory effect Effects 0.000 description 3
• 230000010354 integration Effects 0.000 description 3
• 239000007928 intraperitoneal injection Substances 0.000 description 3
• 208000028867 ischemia Diseases 0.000 description 3
• 238000004519 manufacturing process Methods 0.000 description 3
• 210000001259 mesencephalon Anatomy 0.000 description 3
• CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 3
• 229960000907 methylthioninium chloride Drugs 0.000 description 3
• 238000002493 microarray Methods 0.000 description 3
• 238000000520 microinjection Methods 0.000 description 3
• 230000005012 migration Effects 0.000 description 3
• 238000013508 migration Methods 0.000 description 3
• 230000016273 neuron death Effects 0.000 description 3
• 230000016195 neuron homeostasis Effects 0.000 description 3
• 210000000584 nodose ganglion Anatomy 0.000 description 3
• 230000002474 noradrenergic effect Effects 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 238000006384 oligomerization reaction Methods 0.000 description 3
• 244000052769 pathogen Species 0.000 description 3
• 230000007084 physiological dysfunction Effects 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 108091092562 ribozyme Proteins 0.000 description 3
• 210000004761 scalp Anatomy 0.000 description 3
• 210000002027 skeletal muscle Anatomy 0.000 description 3
• 210000003625 skull Anatomy 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 210000003594 spinal ganglia Anatomy 0.000 description 3
• 230000008685 targeting Effects 0.000 description 3
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 238000011830 transgenic mouse model Methods 0.000 description 3
• 230000001228 trophic effect Effects 0.000 description 3
• 238000011144 upstream manufacturing Methods 0.000 description 3
• 238000012800 visualization Methods 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• 208000030939 Chronic inflammatory demyelinating polyneuropathy Diseases 0.000 description 2
• 239000004971 Cross linker Substances 0.000 description 2
• AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 2
• 101710101225 Diablo IAP-binding mitochondrial protein Proteins 0.000 description 2
• 101710156605 Diablo homolog, mitochondrial Proteins 0.000 description 2
• 102000004190 Enzymes Human genes 0.000 description 2
• 108090000790 Enzymes Proteins 0.000 description 2
• OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
• 241000282326 Felis catus Species 0.000 description 2
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 2
• 241000713858 Harvey murine sarcoma virus Species 0.000 description 2
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 2
• 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 description 2
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
• 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 description 2
• YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 2
• LUWJPTVQOMUZLW-UHFFFAOYSA-N Luxol fast blue MBS Chemical compound [Cu++].Cc1ccccc1N\C(N)=N\c1ccccc1C.Cc1ccccc1N\C(N)=N\c1ccccc1C.OS(=O)(=O)c1cccc2c3nc(nc4nc([n-]c5[n-]c(nc6nc(n3)c3ccccc63)c3c(cccc53)S(O)(=O)=O)c3ccccc43)c12 LUWJPTVQOMUZLW-UHFFFAOYSA-N 0.000 description 2
• 201000011442 Metachromatic leukodystrophy Diseases 0.000 description 2
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 2
• 241000713869 Moloney murine leukemia virus Species 0.000 description 2
• 208000001089 Multiple system atrophy Diseases 0.000 description 2
• 241000699660 Mus musculus Species 0.000 description 2
• 108700028031 Myelin Basic Proteins 0.000 description 2
• OTCCIMWXFLJLIA-UHFFFAOYSA-N N-acetyl-DL-aspartic acid Natural products CC(=O)NC(C(O)=O)CC(O)=O OTCCIMWXFLJLIA-UHFFFAOYSA-N 0.000 description 2
• OTCCIMWXFLJLIA-BYPYZUCNSA-N N-acetyl-L-aspartic acid Chemical compound CC(=O)N[C@H](C(O)=O)CC(O)=O OTCCIMWXFLJLIA-BYPYZUCNSA-N 0.000 description 2
• 208000012902 Nervous system disease Diseases 0.000 description 2
• 229930040373 Paraformaldehyde Natural products 0.000 description 2
• 206010033799 Paralysis Diseases 0.000 description 2
• 102100034314 Parkin coregulated gene protein Human genes 0.000 description 2
• 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 description 2
• 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 2
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 description 2
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
• 208000007400 Relapsing-Remitting Multiple Sclerosis Diseases 0.000 description 2
• 241000714474 Rous sarcoma virus Species 0.000 description 2
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
• 108010000449 TNF-Related Apoptosis-Inducing Ligand Receptors Proteins 0.000 description 2
• 102000002259 TNF-Related Apoptosis-Inducing Ligand Receptors Human genes 0.000 description 2
• 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 description 2
• NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
• 102000000591 Tight Junction Proteins Human genes 0.000 description 2
• 108010002321 Tight Junction Proteins Proteins 0.000 description 2
• 102000004142 Trypsin Human genes 0.000 description 2
• 108090000631 Trypsin Proteins 0.000 description 2
• 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 2
• 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 2
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 2
• 238000010521 absorption reaction Methods 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 239000000908 ammonium hydroxide Substances 0.000 description 2
• 230000006909 anti-apoptosis Effects 0.000 description 2
• 230000000692 anti-sense effect Effects 0.000 description 2
• 230000005775 apoptotic pathway Effects 0.000 description 2
• 230000008335 axon cargo transport Effects 0.000 description 2
• 230000031018 biological processes and functions Effects 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 230000006727 cell loss Effects 0.000 description 2
• 210000003710 cerebral cortex Anatomy 0.000 description 2
• 201000005795 chronic inflammatory demyelinating polyneuritis Diseases 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 230000004186 co-expression Effects 0.000 description 2
• 230000024203 complement activation Effects 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 230000021615 conjugation Effects 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 238000012258 culturing Methods 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 230000002939 deleterious effect Effects 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 239000000975 dye Substances 0.000 description 2
• 201000002491 encephalomyelitis Diseases 0.000 description 2
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 230000000763 evoking effect Effects 0.000 description 2
• 108010052621 fas Receptor Proteins 0.000 description 2
• 102000018823 fas Receptor Human genes 0.000 description 2
• 239000000835 fiber Substances 0.000 description 2
• 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 2
• 230000004927 fusion Effects 0.000 description 2
• 230000012010 growth Effects 0.000 description 2
• 210000002865 immune cell Anatomy 0.000 description 2
• 238000003018 immunoassay Methods 0.000 description 2
• 230000002055 immunohistochemical effect Effects 0.000 description 2
• 230000001771 impaired effect Effects 0.000 description 2
• 230000000415 inactivating effect Effects 0.000 description 2
• 230000006882 induction of apoptosis Effects 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 230000002452 interceptive effect Effects 0.000 description 2
• 150000002500 ions Chemical class 0.000 description 2
• 230000002427 irreversible effect Effects 0.000 description 2
• QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
• 229960003299 ketamine Drugs 0.000 description 2
• 230000002147 killing effect Effects 0.000 description 2
• 208000036546 leukodystrophy Diseases 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 230000033001 locomotion Effects 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 230000014759 maintenance of location Effects 0.000 description 2
• 238000005259 measurement Methods 0.000 description 2
• 230000003340 mental effect Effects 0.000 description 2
• 201000006938 muscular dystrophy Diseases 0.000 description 2
• 230000032405 negative regulation of neuron apoptotic process Effects 0.000 description 2
• 230000009223 neuronal apoptosis Effects 0.000 description 2
• 230000007514 neuronal growth Effects 0.000 description 2
• 230000006576 neuronal survival Effects 0.000 description 2
• 239000001272 nitrous oxide Substances 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• 230000030648 nucleus localization Effects 0.000 description 2
• 230000003287 optical effect Effects 0.000 description 2
• 210000003463 organelle Anatomy 0.000 description 2
• 230000002018 overexpression Effects 0.000 description 2
• 208000021090 palsy Diseases 0.000 description 2
• 229920002866 paraformaldehyde Polymers 0.000 description 2
• 230000008506 pathogenesis Effects 0.000 description 2
• 230000002688 persistence Effects 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 210000001778 pluripotent stem cell Anatomy 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 238000001556 precipitation Methods 0.000 description 2
• 206010063401 primary progressive multiple sclerosis Diseases 0.000 description 2
• 206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 description 2
• 108020001580 protein domains Proteins 0.000 description 2
• 230000001603 reducing effect Effects 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 210000001525 retina Anatomy 0.000 description 2
• 230000002207 retinal effect Effects 0.000 description 2
• 230000001177 retroviral effect Effects 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 210000003497 sciatic nerve Anatomy 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 229940076279 serotonin Drugs 0.000 description 2
• 239000004017 serum-free culture medium Substances 0.000 description 2
• 230000019491 signal transduction Effects 0.000 description 2
• 229910052709 silver Inorganic materials 0.000 description 2
• 239000004332 silver Substances 0.000 description 2
• 229910001961 silver nitrate Inorganic materials 0.000 description 2
• 210000003491 skin Anatomy 0.000 description 2
• 239000000243 solution Substances 0.000 description 2
• 230000003238 somatosensory effect Effects 0.000 description 2
• 230000010473 stable expression Effects 0.000 description 2
• 238000007619 statistical method Methods 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 230000002739 subcortical effect Effects 0.000 description 2
• 230000008093 supporting effect Effects 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• 238000010998 test method Methods 0.000 description 2
• 239000003440 toxic substance Substances 0.000 description 2
• 239000003053 toxin Substances 0.000 description 2
• 238000013518 transcription Methods 0.000 description 2
• 230000035897 transcription Effects 0.000 description 2
• 230000005945 translocation Effects 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• 239000012588 trypsin Substances 0.000 description 2
• 230000009452 underexpressoin Effects 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 230000003827 upregulation Effects 0.000 description 2
• 238000012795 verification Methods 0.000 description 2
• BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 2
• 229960001600 xylazine Drugs 0.000 description 2
• JBFQOLHAGBKPTP-NZATWWQASA-N (2s)-2-[[(2s)-4-carboxy-2-[[3-carboxy-2-[[(2s)-2,6-diaminohexanoyl]amino]propanoyl]amino]butanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)C(CC(O)=O)NC(=O)[C@@H](N)CCCCN JBFQOLHAGBKPTP-NZATWWQASA-N 0.000 description 1
• IPVYMXZYXFFDGW-UHFFFAOYSA-N 1-methylpiperidin-4-ol;hydrochloride Chemical compound Cl.CN1CCC(O)CC1 IPVYMXZYXFFDGW-UHFFFAOYSA-N 0.000 description 1
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
• HNPWTDUZIXAJSA-UHFFFAOYSA-N 5,5-dimethyl-2-(3-methylbutanoyl)cyclohexane-1,3-dione Chemical compound CC(C)CC(=O)C1C(=O)CC(C)(C)CC1=O HNPWTDUZIXAJSA-UHFFFAOYSA-N 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 208000011403 Alexander disease Diseases 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 102000007371 Ataxin-3 Human genes 0.000 description 1
• 241001213911 Avian retroviruses Species 0.000 description 1
• 208000000412 Avitaminosis Diseases 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 208000019352 Blepharospasm-oromandibular dystonia syndrome Diseases 0.000 description 1
• 201000006474 Brain Ischemia Diseases 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 108090000397 Caspase 3 Proteins 0.000 description 1
• 102100029855 Caspase-3 Human genes 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 206010057248 Cell death Diseases 0.000 description 1
• 206010051290 Central nervous system lesion Diseases 0.000 description 1
• 206010053684 Cerebrohepatorenal syndrome Diseases 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 102100039518 Claudin-12 Human genes 0.000 description 1
• 101710197000 Claudin-12 Proteins 0.000 description 1
• 102100040838 Claudin-19 Human genes 0.000 description 1
• 101710196827 Claudin-19 Proteins 0.000 description 1
• 102000004056 Claudin-2 Human genes 0.000 description 1
• 108090000580 Claudin-2 Proteins 0.000 description 1
• 102000004057 Claudin-5 Human genes 0.000 description 1
• 108090000582 Claudin-5 Proteins 0.000 description 1
• 102100038449 Claudin-6 Human genes 0.000 description 1
• 108090000229 Claudin-6 Proteins 0.000 description 1
• 102000018156 Claudin-7 Human genes 0.000 description 1
• 108050007296 Claudin-7 Proteins 0.000 description 1
• 241000833010 Claudius Species 0.000 description 1
• 208000010200 Cockayne syndrome Diseases 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 206010010144 Completed suicide Diseases 0.000 description 1
• 206010010904 Convulsion Diseases 0.000 description 1
• 208000011990 Corticobasal Degeneration Diseases 0.000 description 1
• 108010051219 Cre recombinase Proteins 0.000 description 1
• 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
• DSRJIHMZAQEUJV-UHFFFAOYSA-N Cuprizon Chemical compound C1CCCCC1=NNC(=O)C(=O)NN=C1CCCCC1 DSRJIHMZAQEUJV-UHFFFAOYSA-N 0.000 description 1
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
• 102000001493 Cyclophilins Human genes 0.000 description 1
• 108010068682 Cyclophilins Proteins 0.000 description 1
• 102000018832 Cytochromes Human genes 0.000 description 1
• 108010052832 Cytochromes Proteins 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 108010080611 Cytosine Deaminase Proteins 0.000 description 1
• 101150082208 DIABLO gene Proteins 0.000 description 1
• 241000450599 DNA viruses Species 0.000 description 1
• 201000003863 Dandy-Walker Syndrome Diseases 0.000 description 1
• SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 102100027723 Endogenous retrovirus group K member 6 Rec protein Human genes 0.000 description 1
• 101710091045 Envelope protein Proteins 0.000 description 1
• 102000010911 Enzyme Precursors Human genes 0.000 description 1
• 108010062466 Enzyme Precursors Proteins 0.000 description 1
• 108700024394 Exon Proteins 0.000 description 1
• 108010049003 Fibrinogen Proteins 0.000 description 1
• 102000008946 Fibrinogen Human genes 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• 208000035357 Focal Infection Diseases 0.000 description 1
• 108060003306 Galactosyltransferase Proteins 0.000 description 1
• 102000030902 Galactosyltransferase Human genes 0.000 description 1
• 201000004311 Gilles de la Tourette syndrome Diseases 0.000 description 1
• 206010018341 Gliosis Diseases 0.000 description 1
• 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 1
• 102000006395 Globulins Human genes 0.000 description 1
• 108010044091 Globulins Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 208000004547 Hallucinations Diseases 0.000 description 1
• 239000012981 Hank's balanced salt solution Substances 0.000 description 1
• 208000010496 Heart Arrest Diseases 0.000 description 1
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
• 208000028782 Hereditary disease Diseases 0.000 description 1
• 101000973177 Homo sapiens Nuclear factor interleukin-3-regulated protein Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 208000023105 Huntington disease Diseases 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• 101150027427 ICP4 gene Proteins 0.000 description 1
• 208000026350 Inborn Genetic disease Diseases 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
• 208000028226 Krabbe disease Diseases 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• 208000009829 Lewy Body Disease Diseases 0.000 description 1
• 201000002832 Lewy body dementia Diseases 0.000 description 1
• 208000002569 Machado-Joseph Disease Diseases 0.000 description 1
• 201000005190 Meige syndrome Diseases 0.000 description 1
• 201000009906 Meningitis Diseases 0.000 description 1
• 208000019695 Migraine disease Diseases 0.000 description 1
• 241000714177 Murine leukemia virus Species 0.000 description 1
• 102100026784 Myelin proteolipid protein Human genes 0.000 description 1
• 241000713883 Myeloproliferative sarcoma virus Species 0.000 description 1
• 241000244206 Nematoda Species 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 108050003475 Neuregulin Proteins 0.000 description 1
• 102000014413 Neuregulin Human genes 0.000 description 1
• 102100026379 Neurofibromin Human genes 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 241000088844 Nothocestrum Species 0.000 description 1
• 102100022163 Nuclear factor interleukin-3-regulated protein Human genes 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 102000003940 Occludin Human genes 0.000 description 1
• 108090000304 Occludin Proteins 0.000 description 1
• 238000002944 PCR assay Methods 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241000282577 Pan troglodytes Species 0.000 description 1
• 208000017493 Pelizaeus-Merzbacher disease Diseases 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 208000000474 Poliomyelitis Diseases 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 101710188315 Protein X Proteins 0.000 description 1
• 108010065868 RNA polymerase SP6 Proteins 0.000 description 1
• 238000011530 RNeasy Mini Kit Methods 0.000 description 1
• 101001018324 Rattus norvegicus Myelin basic protein Proteins 0.000 description 1
• 208000005587 Refsum Disease Diseases 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 108091027981 Response element Proteins 0.000 description 1
• 241000712909 Reticuloendotheliosis virus Species 0.000 description 1
• 206010038997 Retroviral infections Diseases 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 229910021607 Silver chloride Inorganic materials 0.000 description 1
• 101150046134 Slc33a1 gene Proteins 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 208000036834 Spinocerebellar ataxia type 3 Diseases 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 206010042928 Syringomyelia Diseases 0.000 description 1
• 101710137500 T7 RNA polymerase Proteins 0.000 description 1
• 208000000323 Tourette Syndrome Diseases 0.000 description 1
• 208000016620 Tourette disease Diseases 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
• 206010046865 Vaccinia virus infection Diseases 0.000 description 1
• 201000004810 Vascular dementia Diseases 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 206010047627 Vitamin deficiencies Diseases 0.000 description 1
• 241000021375 Xenogenes Species 0.000 description 1
• 201000004525 Zellweger Syndrome Diseases 0.000 description 1
• 208000036813 Zellweger spectrum disease Diseases 0.000 description 1
• LEBBDRXHHNYZIA-LDUWYPJVSA-N [(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] n-[(z)-1,3-dihydroxyoctadec-4-en-2-yl]carbamate Chemical compound CCCCCCCCCCCCC\C=C/C(O)C(CO)NC(=O)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O LEBBDRXHHNYZIA-LDUWYPJVSA-N 0.000 description 1
• SPSGYTWOIGAABK-DQEYMECFSA-N [4-[(2s)-2-acetamido-3-[[(5s)-3-carbamoyl-2-(cyclohexylmethoxy)-6,7,8,9-tetrahydro-5h-benzo[7]annulen-5-yl]amino]-3-oxopropyl]-2-phosphonophenyl]phosphonic acid Chemical compound C([C@H](NC(=O)C)C(=O)N[C@@H]1C2=CC(=C(OCC3CCCCC3)C=C2CCCC1)C(N)=O)C1=CC=C(P(O)(O)=O)C(P(O)(O)=O)=C1 SPSGYTWOIGAABK-DQEYMECFSA-N 0.000 description 1
• NOSIYYJFMPDDSA-UHFFFAOYSA-N acepromazine Chemical compound C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 NOSIYYJFMPDDSA-UHFFFAOYSA-N 0.000 description 1
• 229960005054 acepromazine Drugs 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 208000037919 acquired disease Diseases 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000009798 acute exacerbation Effects 0.000 description 1
• 230000001464 adherent effect Effects 0.000 description 1
• 208000030597 adult Refsum disease Diseases 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 230000002776 aggregation Effects 0.000 description 1
• 238000004220 aggregation Methods 0.000 description 1
• 229940050528 albumin Drugs 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 238000000540 analysis of variance Methods 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 238000003782 apoptosis assay Methods 0.000 description 1
• 229910052786 argon Inorganic materials 0.000 description 1
• 238000003491 array Methods 0.000 description 1
• 238000013096 assay test Methods 0.000 description 1
• 230000007844 axonal damage Effects 0.000 description 1
• 108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
• 210000004227 basal ganglia Anatomy 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 230000002146 bilateral effect Effects 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 238000006664 bond formation reaction Methods 0.000 description 1
• 230000006931 brain damage Effects 0.000 description 1
• 231100000874 brain damage Toxicity 0.000 description 1
• 208000029028 brain injury Diseases 0.000 description 1
• 210000000133 brain stem Anatomy 0.000 description 1
• 244000309464 bull Species 0.000 description 1
• 230000000981 bystander Effects 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 230000008614 cellular interaction Effects 0.000 description 1
• 230000007541 cellular toxicity Effects 0.000 description 1
• 208000009885 central pontine myelinolysis Diseases 0.000 description 1
• 206010008129 cerebral palsy Diseases 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 102000004361 claudin 10 Human genes 0.000 description 1
• 108090000999 claudin 10 Proteins 0.000 description 1
• OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
• 238000001360 collision-induced dissociation Methods 0.000 description 1
• 230000001332 colony forming effect Effects 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 230000002508 compound effect Effects 0.000 description 1
• 239000003636 conditioned culture medium Substances 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 230000036461 convulsion Effects 0.000 description 1
• 210000004087 cornea Anatomy 0.000 description 1
• 230000009537 cortical lesion Effects 0.000 description 1
• 239000000287 crude extract Substances 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 229940095074 cyclic amp Drugs 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 230000003412 degenerative effect Effects 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 210000001787 dendrite Anatomy 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 230000002951 depilatory effect Effects 0.000 description 1
• 230000000994 depressogenic effect Effects 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 230000006866 deterioration Effects 0.000 description 1
• 229960002086 dextran Drugs 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 230000005014 ectopic expression Effects 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 210000002257 embryonic structure Anatomy 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 230000006353 environmental stress Effects 0.000 description 1
• 210000001339 epidermal cell Anatomy 0.000 description 1
• 210000002615 epidermis Anatomy 0.000 description 1
• 206010015037 epilepsy Diseases 0.000 description 1
• 201000006517 essential tremor Diseases 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 238000010195 expression analysis Methods 0.000 description 1
• 229940012952 fibrinogen Drugs 0.000 description 1
• 238000001917 fluorescence detection Methods 0.000 description 1
• 230000000574 ganglionic effect Effects 0.000 description 1
• 238000001476 gene delivery Methods 0.000 description 1
• 208000016361 genetic disease Diseases 0.000 description 1
• 230000007387 gliosis Effects 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 230000007946 glucose deprivation Effects 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
• 239000008241 heterogeneous mixture Substances 0.000 description 1
• 230000009097 homeostatic mechanism Effects 0.000 description 1
• 208000003906 hydrocephalus Diseases 0.000 description 1
• 230000007954 hypoxia Effects 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 238000003125 immunofluorescent labeling Methods 0.000 description 1
• 238000005470 impregnation Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 210000004969 inflammatory cell Anatomy 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 239000004615 ingredient Substances 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 229960002725 isoflurane Drugs 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 206010023497 kuru Diseases 0.000 description 1
• 201000010901 lateral sclerosis Diseases 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 108010089256 lysyl-aspartyl-glutamyl-leucine Proteins 0.000 description 1
• 210000005171 mammalian brain Anatomy 0.000 description 1
• 241001515942 marmosets Species 0.000 description 1
• 230000013011 mating Effects 0.000 description 1
• 238000002483 medication Methods 0.000 description 1
• QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
• 229910052753 mercury Inorganic materials 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
• 239000003094 microcapsule Substances 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 230000009456 molecular mechanism Effects 0.000 description 1
• 230000004784 molecular pathogenesis Effects 0.000 description 1
• 208000005264 motor neuron disease Diseases 0.000 description 1
• 239000012120 mounting media Substances 0.000 description 1
• 230000003387 muscular Effects 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• CAMWVBRDIKKGII-UHFFFAOYSA-M n,n-dimethyl-4-(1-methylpyridin-1-ium-4-yl)aniline;iodide Chemical compound [I-].C1=CC(N(C)C)=CC=C1C1=CC=[N+](C)C=C1 CAMWVBRDIKKGII-UHFFFAOYSA-M 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000008904 neural response Effects 0.000 description 1
• 230000000926 neurological effect Effects 0.000 description 1
• 230000019581 neuron apoptotic process Effects 0.000 description 1
• 230000004693 neuron damage Effects 0.000 description 1
• 230000007512 neuronal protection Effects 0.000 description 1
• 229910017604 nitric acid Inorganic materials 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 230000001473 noxious effect Effects 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 230000028266 oligodendrocyte apoptotic process Effects 0.000 description 1
• 230000003606 oligomerizing effect Effects 0.000 description 1
• 208000031237 olivopontocerebellar atrophy Diseases 0.000 description 1
• 210000001328 optic nerve Anatomy 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 230000036542 oxidative stress Effects 0.000 description 1
• 239000006179 pH buffering agent Substances 0.000 description 1
• 238000002559 palpation Methods 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 231100000915 pathological change Toxicity 0.000 description 1
• 230000036285 pathological change Effects 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 102000013415 peroxidase activity proteins Human genes 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 239000008177 pharmaceutical agent Substances 0.000 description 1
• 239000000825 pharmaceutical preparation Substances 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 238000005375 photometry Methods 0.000 description 1
• 231100000614 poison Toxicity 0.000 description 1
• 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000004321 preservation Methods 0.000 description 1
• 238000003825 pressing Methods 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 230000005522 programmed cell death Effects 0.000 description 1
• 230000001902 propagating effect Effects 0.000 description 1
• 210000004129 prosencephalon Anatomy 0.000 description 1
• 238000000164 protein isolation Methods 0.000 description 1
• 239000012474 protein marker Substances 0.000 description 1
• 239000012673 purified plant extract Substances 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 239000000700 radioactive tracer Substances 0.000 description 1
• 238000003753 real-time PCR Methods 0.000 description 1
• 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
• 108010054624 red fluorescent protein Proteins 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 230000029058 respiratory gaseous exchange Effects 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 230000020874 response to hypoxia Effects 0.000 description 1
• 230000008458 response to injury Effects 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108020004418 ribosomal RNA Proteins 0.000 description 1
• 238000011808 rodent model Methods 0.000 description 1
• 239000012266 salt solution Substances 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 230000001953 sensory effect Effects 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 239000013605 shuttle vector Substances 0.000 description 1
• HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
• 235000019345 sodium thiosulphate Nutrition 0.000 description 1
• 210000004092 somatosensory cortex Anatomy 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 208000020431 spinal cord injury Diseases 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 230000001954 sterilising effect Effects 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 230000009747 swallowing Effects 0.000 description 1
• 230000005062 synaptic transmission Effects 0.000 description 1
• 231100000057 systemic toxicity Toxicity 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 229960001603 tamoxifen Drugs 0.000 description 1
• 230000003797 telogen phase Effects 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 238000001161 time-correlated single photon counting Methods 0.000 description 1
• 238000001954 time-lapse fluorescence microscopy Methods 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 210000003014 totipotent stem cell Anatomy 0.000 description 1
• 231100000167 toxic agent Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 238000012549 training Methods 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 208000007089 vaccinia Diseases 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 108700026220 vif Genes Proteins 0.000 description 1
• 238000007794 visualization technique Methods 0.000 description 1
• 230000002747 voluntary effect Effects 0.000 description 1
• 230000021542 voluntary musculoskeletal movement Effects 0.000 description 1
• 239000002699 waste material Substances 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 210000004885 white matter Anatomy 0.000 description 1
• 239000012224 working solution Substances 0.000 description 1